Immunovant, Inc.
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionXTX Topco Ltd
Latest Disclosed Ownership203,029 shares
Latest Disclosed Value $ 5,043,240
XTX Topco Ltd reports 512.97% increase in ownership of IMVT / Immunovant, Inc.

On May 15, 2026 - XTX Topco Ltd filed a 13F-HR form disclosing ownership of 203,029 shares of Immunovant, Inc. (US:IMVT) valued at $5,043,240 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 33,122 shares of Immunovant, Inc.. This represents a change in shares of 512.97% during the quarter. The current value of the position is $6,632,957 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNOVANT COM 45258J102 203,029 169,907 512.97 5,043 499.64 0.0877
2026-02-17 2025-12-31 13F IMMUNOVANT COM 45258J102 33,122 15,795 91.16 842 201.43 0.0221
2025-11-14 2025-09-30 13F IMMUNOVANT COM 45258J102 17,327 -63,861 -78.66 279 -78.52 0.0145
2025-08-12 2025-06-30 13F IMMUNOVANT COM 45258J102 81,188 81,188 1,299 0.0539
2025-05-08 2025-03-31 13F IMMUNOVANT COM 45258J102 0 -22,740 -100.00 0 -100.00
2025-02-13 2024-12-31 13F IMMUNOVANT COM 45258J102 22,740 22,740 563 0.0463
2024-08-12 2024-06-30 13F IMMUNOVANT COM 45258J102 0 -9,237 -100.00 0 -100.00
2024-05-13 2024-03-31 13F IMMUNOVANT COM 45258J102 9,237 9,237 298 0.0402
2023-08-14 2023-06-30 13F IMMUNOVANT COM 45258J102 0 -20,548 -100.00 0 -100.00
2023-05-12 2023-03-31 13F IMMUNOVANT COM 45258J102 20,548 20,548 319 0.0668
2022-02-11 2021-12-31 13F IMMUNOVANT COM 45258J102 0 -15,418 -100.00 0 -100.00
2021-11-12 2021-09-30 13F IMMUNOVANT COM 45258J102 15,418 15,418 134 0.0450
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.